<code id='07C7C77C99'></code><style id='07C7C77C99'></style>
    • <acronym id='07C7C77C99'></acronym>
      <center id='07C7C77C99'><center id='07C7C77C99'><tfoot id='07C7C77C99'></tfoot></center><abbr id='07C7C77C99'><dir id='07C7C77C99'><tfoot id='07C7C77C99'></tfoot><noframes id='07C7C77C99'>

    • <optgroup id='07C7C77C99'><strike id='07C7C77C99'><sup id='07C7C77C99'></sup></strike><code id='07C7C77C99'></code></optgroup>
        1. <b id='07C7C77C99'><label id='07C7C77C99'><select id='07C7C77C99'><dt id='07C7C77C99'><span id='07C7C77C99'></span></dt></select></label></b><u id='07C7C77C99'></u>
          <i id='07C7C77C99'><strike id='07C7C77C99'><tt id='07C7C77C99'><pre id='07C7C77C99'></pre></tt></strike></i>

          leisure time

          leisure time

          author:fashion    Page View:715
          Miniature people figurines standing in a group looking down. -- health tech coverage from STAT
          Adobe

          In less than two years, digital health’s high-flying class of public debuts have landed with a resounding thud.

          Accelerated by the pandemic’s forced adoption of telehealth and other digital health solutions, 2021 saw more than 30 health technology startups go public, raising hundreds of millions and in some cases billions of dollars. Today, three members of the class of 2021 have gone bankrupt. Twelve companies have lost more than 90% of their initial value, including Bright Health Group, Cue Health, and Better Therapeutics. And dangerously low reserves have inspired desperate moves to slash costs, drum up liquidity, and find buyers.

          advertisement

          Most recently, the bankruptcy of digital primary care company Babylon Health has drawn attention to the plight of newly-public health tech companies, and how the froth of dealmaking at the height of the pandemic led to overblown valuations. Before its debut in June 2021, Babylon was valued at $4.2 billion; after filing for bankruptcy in August, its U.K. telemedicine business was sold for just over $600,000.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          comprehensive

          Alkermes shareholders re
          Alkermes shareholders re

          MarkLennihan/APAlkermesshareholdersvotedThursdaytore-electallofthedrugmaker’scurrentdirectors,ending

          read more
          European regulators consider appeal over Amylyx ALS drug
          European regulators consider appeal over Amylyx ALS drug

          PauloAmorim/VWPicsviaAPImagesLONDON—Thisweek,EuropeanregulatorsareconsideringanappealfromAmylyxPharm

          read more
          Tori Bowie and the unacceptable rates of Black maternal death
          Tori Bowie and the unacceptable rates of Black maternal death

          AlastairGrant/APThehorrorstoriesofBlackwomendyingorcomingclosetodeathinchildbirthneverseemtostopcomi

          read more

          2024 GOP presidential candidates spar over abortion in debate

          APPhoto/MorryGashWASHINGTON—RepublicanpresidentialcandidatessparredWednesdayoveraquestionthathashaun